Physician profile
John A Allen
NPI 1922002815
$838.07
in general payments reported to CMS, 2019-2025
10 companies · $93.49 in 2025
The $93.49 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $125 · 2021: $168 · 2022: $116 · 2023: $30.24 · 2024: $86.62 · 2025: $93.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $274.55 | 2019-2024 | Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $161.49 | 2019-2025 | Abilify Maintena, Abilify Asimtufii |
| Alkermes, INC. | $120.76 | 2019-2022 | |
| Glaxosmithkline, LLC. | $80.87 | 2020-2023 | Bexsero |
| Springworks Therapeutics, INC. | $55.96 | 2024-2025 | Ogsiveo |
| Sunovion Pharmaceuticals INC. | $46.51 | 2019-2020 | |
| Mindray Ds USA, INC. | $41.30 | 2024 | Na Electrode,Indirect,International, Patient Monitor |
| E.R. Squibb & Sons, L.L.C. | $27.02 | 2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $15.52 | 2025 | Uzedy |
| Abbvie INC. | $14.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.